March 20, 2014 | A clinical trial out of the Mount Sinai School of Medicine in New York crowd-sourced its protocol, getting input from 43 physicians and 33 patients. They used Protocol Builder from Transparency Life Sciences. The trial is expected to begin accrual this spring. Oncology Times